Published in
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology, Journal of Gynecologic Oncology, 1(32), 2021
Links
Tools
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial
Journal article published in 2021 by
Takashi Motohashi 
,
Akira Yabuno ,
Hiroshi Michimae ,
Tetsuro Ohishi ,
Miwa Nonaka ,
Masashi Takano ,
Shin Nishio ,
Hiroyuki Fujiwara ,
Keiichi Fujiwara ,
Eiji Kondo ,
Toru Sugiyama ,
Tsutomu Tabata
,
Akira Yabuno ,
Hiroshi Michimae ,
Tetsuro Ohishi ,
Miwa Nonaka ,
Masashi Takano ,
Shin Nishio ,
Hiroyuki Fujiwara ,
Keiichi Fujiwara ,
Eiji Kondo ,
Toru Sugiyama ,
Tsutomu Tabata
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 